APO RESEARCH · REPORT
Ketoprofen
Ketoprofen is a nonsteroidal anti-inflammatory drug with analgesic and antipyretic effects. It is used to relieve the signs and symptoms of rheumatoid arthritis and osteoarthritis. It is also used to relieve mild to moderate pain, as well as menstrual pain.
Product & engineering
Understand the product.
Ketoprofen is a nonsteroidal anti-inflammatory drug with analgesic and antipyretic effects. It is used to relieve the signs and symptoms of rheumatoid arthritis and osteoarthritis. It is also used to relieve mild to moderate pain, as well as menstrual pain.
In this research the statistics are Ketoprofen BPC (bulk pharmaceutical chemicals).
Selected research
Market Outlook & Growth Opportunities
Global Ketoprofen Market Outlook and Growth Opportunities 2026
Market perspective
Ketoprofen is a nonsteroidal anti-inflammatory drug with analgesic and antipyretic effects. It is used to relieve the signs and symptoms of rheumatoid arthritis and osteoarthritis. It is also used to relieve mild to moderate pain, as well as menstrual pain.
In this research the statistics are Ketoprofen BPC (bulk pharmaceutical chemicals).
China is the largest Ketoprofen market with about 68% market share. Europe is follower, accounting for about 18% market share.
Read the full market overview
The key players are SANOFI-Aventis, Boehringer-Ingelheim, BEC, Zhejiang Jiuzhou, Hubei Xunda etc. Top 3 companies occupied about 83% market share.
This report provides an overview of the global Ketoprofen market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Ketoprofen and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Ketoprofen sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ketoprofen market size, projected growth trends, production technologies, key applications, and end-use industries.
Ketoprofen Segment by Company
SANOFI-Aventis
Boehringer-Ingelheim
BEC
Zhejiang Jiuzhou
Hubei Xunda
Ketoprofen Segment by Type
Ketoprofen above 99.5%
Ketoprofen below 99.5%
Ketoprofen Segment by Application
Ketoprofen Tablets
Ketoprofen Capsules
Ketoprofen Gel
Others
Ketoprofen Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Ketoprofen status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Ketoprofen market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Ketoprofen significant trends, drivers, influence factors in global and regions.
6. To analyze Ketoprofen competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ketoprofen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ketoprofen and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ketoprofen.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Ketoprofen market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ketoprofen industry.
Chapter 3: Detailed analysis of Ketoprofen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Ketoprofen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Ketoprofen in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Ketoprofen above 99.5%
- Ketoprofen below 99.5%
Applications
- Ketoprofen Tablets
- Ketoprofen Capsules
- Ketoprofen Gel
- Others
Companies covered
- SANOFI-Aventis
- Boehringer-Ingelheim
- BEC
- Zhejiang Jiuzhou
- Hubei Xunda
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Ketoprofen Sales Value (2021-2032)
- 1.2.2 Global Ketoprofen Sales Volume (2021-2032)
- 1.2.3 Global Ketoprofen Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Ketoprofen Market Dynamics
- 2.1 Ketoprofen Industry Trends
- 2.2 Ketoprofen Industry Drivers
- 2.3 Ketoprofen Industry Opportunities and Challenges
- 2.4 Ketoprofen Industry Restraints
3 Ketoprofen Market by Company
- 3.1 Global Ketoprofen Company Revenue Ranking in 2025
- 3.2 Global Ketoprofen Revenue by Company (2021-2026)
- 3.3 Global Ketoprofen Sales Volume by Company (2021-2026)
- 3.4 Global Ketoprofen Average Price by Company (2021-2026)
- 3.5 Global Ketoprofen Company Ranking (2024-2026)
- 3.6 Global Ketoprofen Company Manufacturing Base and Headquarters
- 3.7 Global Ketoprofen Company Product Type and Application
- 3.8 Global Ketoprofen Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Ketoprofen Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Ketoprofen Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Ketoprofen Market by Type
- 4.1 Ketoprofen Type Introduction
- 4.1.1 Ketoprofen above 99.5%
- 4.1.2 Ketoprofen below 99.5%
- 4.2 Global Ketoprofen Sales Volume by Type
- 4.2.1 Global Ketoprofen Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Ketoprofen Sales Volume by Type (2021-2032)
- 4.2.3 Global Ketoprofen Sales Volume Share by Type (2021-2032)
- 4.3 Global Ketoprofen Sales Value by Type
- 4.3.1 Global Ketoprofen Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Ketoprofen Sales Value by Type (2021-2032)
- 4.3.3 Global Ketoprofen Sales Value Share by Type (2021-2032)
5 Ketoprofen Market by Application
- 5.1 Ketoprofen Application Introduction
- 5.1.1 Ketoprofen Tablets
- 5.1.2 Ketoprofen Capsules
- 5.1.3 Ketoprofen Gel
- 5.1.4 Others
- 5.2 Global Ketoprofen Sales Volume by Application
- 5.2.1 Global Ketoprofen Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Ketoprofen Sales Volume by Application (2021-2032)
- 5.2.3 Global Ketoprofen Sales Volume Share by Application (2021-2032)
- 5.3 Global Ketoprofen Sales Value by Application
- 5.3.1 Global Ketoprofen Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Ketoprofen Sales Value by Application (2021-2032)
- 5.3.3 Global Ketoprofen Sales Value Share by Application (2021-2032)
6 Ketoprofen Regional Sales and Value Analysis
- 6.1 Global Ketoprofen Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Ketoprofen Sales by Region (2021-2032)
- 6.2.1 Global Ketoprofen Sales by Region: 2021-2026
- 6.2.2 Global Ketoprofen Sales by Region (2027-2032)
- 6.3 Global Ketoprofen Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Ketoprofen Sales Value by Region (2021-2032)
- 6.4.1 Global Ketoprofen Sales Value by Region: 2021-2026
- 6.4.2 Global Ketoprofen Sales Value by Region (2027-2032)
- 6.5 Global Ketoprofen Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Ketoprofen Sales Value (2021-2032)
- 6.6.2 North America Ketoprofen Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Ketoprofen Sales Value (2021-2032)
- 6.7.2 Europe Ketoprofen Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Ketoprofen Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Ketoprofen Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Ketoprofen Sales Value (2021-2032)
- 6.9.2 South America Ketoprofen Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Ketoprofen Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Ketoprofen Sales Value Share by Country, 2025 VS 2032
7 Ketoprofen Country-level Sales and Value Analysis
- 7.1 Global Ketoprofen Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Ketoprofen Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Ketoprofen Sales by Country (2021-2032)
- 7.3.1 Global Ketoprofen Sales by Country (2021-2026)
- 7.3.2 Global Ketoprofen Sales by Country (2027-2032)
- 7.4 Global Ketoprofen Sales Value by Country (2021-2032)
- 7.4.1 Global Ketoprofen Sales Value by Country (2021-2026)
- 7.4.2 Global Ketoprofen Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.9.2 France Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.16.2 China Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.19.2 India Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Ketoprofen Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Ketoprofen Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Ketoprofen Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Ketoprofen Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 SANOFI-Aventis
- 8.1.1 SANOFI-Aventis Company Information
- 8.1.2 SANOFI-Aventis Business Overview
- 8.1.3 SANOFI-Aventis Ketoprofen Sales, Value and Gross Margin (2021-2026)
- 8.1.4 SANOFI-Aventis Ketoprofen Product Portfolio
- 8.1.5 SANOFI-Aventis Recent Developments
- 8.2 Boehringer-Ingelheim
- 8.2.1 Boehringer-Ingelheim Company Information
- 8.2.2 Boehringer-Ingelheim Business Overview
- 8.2.3 Boehringer-Ingelheim Ketoprofen Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Boehringer-Ingelheim Ketoprofen Product Portfolio
- 8.2.5 Boehringer-Ingelheim Recent Developments
- 8.3 BEC
- 8.3.1 BEC Company Information
- 8.3.2 BEC Business Overview
- 8.3.3 BEC Ketoprofen Sales, Value and Gross Margin (2021-2026)
- 8.3.4 BEC Ketoprofen Product Portfolio
- 8.3.5 BEC Recent Developments
- 8.4 Zhejiang Jiuzhou
- 8.4.1 Zhejiang Jiuzhou Company Information
- 8.4.2 Zhejiang Jiuzhou Business Overview
- 8.4.3 Zhejiang Jiuzhou Ketoprofen Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Zhejiang Jiuzhou Ketoprofen Product Portfolio
- 8.4.5 Zhejiang Jiuzhou Recent Developments
- 8.5 Hubei Xunda
- 8.5.1 Hubei Xunda Company Information
- 8.5.2 Hubei Xunda Business Overview
- 8.5.3 Hubei Xunda Ketoprofen Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Hubei Xunda Ketoprofen Product Portfolio
- 8.5.5 Hubei Xunda Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Ketoprofen Value Chain Analysis
- 9.1.1 Ketoprofen Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Ketoprofen Sales Mode & Process
- 9.2 Ketoprofen Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Ketoprofen Distributors
- 9.2.3 Ketoprofen Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst